Clinical & Diagnostic

Meiji Seika Pharma Reports Positive Phase III Data for Nacubactam in Complicated UTIs

Lancet-published Integral-1 results support nacubactam’s potential as a new option against drug-resistant Gram-negative infections ...

Cepheid Receives CE Marking Under IVDR for Xpert GI Panel

IVDR-compliant PCR test supports the detection of 11 clinically relevant gastrointestinal pathogens from 1 sample...

Sebia India Collaborates with CAHO to Launch Autoimmunity Masterclass Series to Strengthen Early Diagnosis and Clinical Excellence

India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....

Ventric Health Updates Digital Platform to Support Earlier Heart Failure Detection

The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings. ...

Chance Pharma’s CXG87 Moves Into China Regulatory Review for Asthma Treatment

The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...

Getting a leg up on diabetic lower extremity amputation with new AI risk prediction model

Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...

FutureLife Becomes First European Fertility Network to Adopt an End-to-End AI Fertility Platform

Network-wide partnership with Alife Health brings a comprehensive AI platform for fertility care, including CE-marked Embryo Predict, to clinics across 16 countries...

Dentsply Sirona Introduces AI-Powered PARL Detection Solution

The AI-assisted support feature is designed to help clinicians review CBCT scans more efficiently and clearly when evaluating potential periapical radiolucencies (PARLs)...

NAMSA and Lexitas Partner to Deliver End-to-End Ophthalmic Medical Device Development

Strategic collaboration combines global MedTech development capabilities with specialised ophthalmic expertise to streamline innovation...

An app that improves decision-making: Duke-NUS study shows myKIDNEY helps patients make better informed choices

Duke-NUS researchers find that pairing a web-based decision-aid with counselling helps elderly patients with end-stage kidney disease and their caregivers make better informed treatment choices – and significantly shifts decisions towards care that prioritises comfort and quality of life....